261 related articles for article (PubMed ID: 21903115)
1. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
Koike H; Iijima M; Chaki S
Neuropharmacology; 2011 Dec; 61(8):1419-23. PubMed ID: 21903115
[TBL] [Abstract][Full Text] [Related]
2. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
Koike H; Fukumoto K; Iijima M; Chaki S
Behav Brain Res; 2013 Feb; 238():48-52. PubMed ID: 23098797
[TBL] [Abstract][Full Text] [Related]
3. On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.
Pałucha-Poniewiera A; Wierońska JM; Brański P; Stachowicz K; Chaki S; Pilc A
Psychopharmacology (Berl); 2010 Dec; 212(4):523-35. PubMed ID: 20703449
[TBL] [Abstract][Full Text] [Related]
4. MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.
Chaki S; Yoshikawa R; Hirota S; Shimazaki T; Maeda M; Kawashima N; Yoshimizu T; Yasuhara A; Sakagami K; Okuyama S; Nakanishi S; Nakazato A
Neuropharmacology; 2004 Mar; 46(4):457-67. PubMed ID: 14975669
[TBL] [Abstract][Full Text] [Related]
5. AMPA receptor stimulation mediates the antidepressant-like effect of a group II metabotropic glutamate receptor antagonist.
Karasawa J; Shimazaki T; Kawashima N; Chaki S
Brain Res; 2005 Apr; 1042(1):92-8. PubMed ID: 15823257
[TBL] [Abstract][Full Text] [Related]
6. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
Koike H; Chaki S
Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
[TBL] [Abstract][Full Text] [Related]
7. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
[TBL] [Abstract][Full Text] [Related]
8. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
Fukumoto K; Iijima M; Chaki S
Psychopharmacology (Berl); 2014 Jun; 231(11):2291-8. PubMed ID: 24402133
[TBL] [Abstract][Full Text] [Related]
9. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
[TBL] [Abstract][Full Text] [Related]
10. Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test.
Shimazaki T; Iijima M; Chaki S
Eur J Pharmacol; 2004 Oct; 501(1-3):121-5. PubMed ID: 15464070
[TBL] [Abstract][Full Text] [Related]
11. Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex.
Marek GJ; Wright RA; Schoepp DD; Monn JA; Aghajanian GK
J Pharmacol Exp Ther; 2000 Jan; 292(1):76-87. PubMed ID: 10604933
[TBL] [Abstract][Full Text] [Related]
12. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
Podkowa K; Pochwat B; Brański P; Pilc A; Pałucha-Poniewiera A
Psychopharmacology (Berl); 2016 Aug; 233(15-16):2901-14. PubMed ID: 27286960
[TBL] [Abstract][Full Text] [Related]
13. The metabotropic glutamate (mGLU)2/3 receptor antagonist LY341495 [2S-2-amino-2-(1S,2S-2-carboxycyclopropyl-1-yl)-3-(xanth-9-yl)propanoic acid] stimulates waking and fast electroencephalogram power and blocks the effects of the mGLU2/3 receptor agonist ly379268 [(-)-2-oxa-4-aminobicyclo[3.1.0]hexane-4,6-dicarboxylate] in rats.
Feinberg I; Schoepp DD; Hsieh KC; Darchia N; Campbell IG
J Pharmacol Exp Ther; 2005 Feb; 312(2):826-33. PubMed ID: 15383637
[TBL] [Abstract][Full Text] [Related]
14. Effects of metabotropic glutamate 2/3 receptor antagonists in the stress-induced hyperthermia test in singly housed mice.
Iijima M; Shimazaki T; Ito A; Chaki S
Psychopharmacology (Berl); 2007 Feb; 190(2):233-9. PubMed ID: 17102982
[TBL] [Abstract][Full Text] [Related]
15. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
Dong C; Zhang JC; Yao W; Ren Q; Ma M; Yang C; Chaki S; Hashimoto K
Int J Neuropsychopharmacol; 2017 Mar; 20(3):228-236. PubMed ID: 27765808
[TBL] [Abstract][Full Text] [Related]
16. (
Zanos P; Highland JN; Stewart BW; Georgiou P; Jenne CE; Lovett J; Morris PJ; Thomas CJ; Moaddel R; Zarate CA; Gould TD
Proc Natl Acad Sci U S A; 2019 Mar; 116(13):6441-6450. PubMed ID: 30867285
[TBL] [Abstract][Full Text] [Related]
17. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
Pałucha-Poniewiera A; Szewczyk B; Pilc A
Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like activity of the mGLU2/3 receptor agonist LY354740 in the elevated plus maze test is disrupted in metabotropic glutamate receptor 2 and 3 knock-out mice.
Linden AM; Shannon H; Baez M; Yu JL; Koester A; Schoepp DD
Psychopharmacology (Berl); 2005 Apr; 179(1):284-91. PubMed ID: 15619115
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of metabotropic glutamate (mGlu) 2 receptor and blockade of mGlu1 receptor improve social memory impairment elicited by MK-801 in rats.
Hikichi H; Kaku A; Karasawa J; Chaki S
J Pharmacol Sci; 2013; 122(1):10-6. PubMed ID: 23603933
[TBL] [Abstract][Full Text] [Related]
20. Neuropharmacological profiles of antagonists of group II metabotropic glutamate receptors.
Kawashima N; Karasawa J; Shimazaki T; Chaki S; Okuyama S; Yasuhara A; Nakazato A
Neurosci Lett; 2005 Apr; 378(3):131-4. PubMed ID: 15781145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
